Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and Their Clinical Implications
Devis Pascut, Muhammad Yogi Pratama, Niệm Văn Thành Võ, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 823-823
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Molecular therapies for HCC: Looking outside the box
Sandrine Faivre, Lorenza Rimassa, Richard S. Finn
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 342-352
Open Access | Times Cited: 300
The role of Exosomal miRNAs in cancer
Chuanyun Li, Tong Zhou, Jing Chen, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 99
Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling
Junlong Zhao, Huichen Li, Shoujie Zhao, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 87
Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization
Yong Wang, Rongfen Gao, Jinpeng Li, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 2803-2818
Open Access | Times Cited: 87
Cell–cell communication inference and analysis in the tumour microenvironments from single-cell transcriptomics: data resources and computational strategies
Lihong Peng, Feixiang Wang, Zhao Wang, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 4
Closed Access | Times Cited: 67
Tumor microbiome – an integral part of the tumor microenvironment
Sona Ciernikova, Aneta Sevcikova, Viola Stevurkova, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 38
Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma
Shuying Chen, Yinqi Mao, Wei Chen, et al.
Journal of Cancer (2022) Vol. 13, Iss. 5, pp. 1410-1417
Open Access | Times Cited: 31
Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Goh, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 741-764
Closed Access | Times Cited: 29
Exosome-transmitted circ IFNGR2 Modulates Ovarian Cancer Metastasis via miR-378/ST5 Axis
Xiaoping Chen, Xinping Ren, E Jiaoting, et al.
Molecular and Cellular Biology (2023) Vol. 43, Iss. 1, pp. 22-42
Open Access | Times Cited: 19
Exosome in Hepatocellular Carcinoma: an update
Wei Chen, Yinqi Mao, Chenbin Liu, et al.
Journal of Cancer (2021) Vol. 12, Iss. 9, pp. 2526-2536
Open Access | Times Cited: 35
Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies
Kevin Park, Mysore S. Veena, Daniel Sanghoon Shin
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 27
EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome
Narjara González Suárez, Yuniel Fernández‐Marrero, Sima Torabidastgerdooei, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 1099-1099
Open Access | Times Cited: 27
Transforming native exosomes to engineered drug vehicles: A smart solution to modern cancer theranostics
Rajeev Kumar Sahoo, Surya Kant Tripathi, Stuti Biswal, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 2
Closed Access | Times Cited: 5
Application of multi-omics in hepatocellular carcinoma: new prospects for classification and precise diagnosis and treatment
Jiaxue He, Xintong Hu, Liguo Chen, et al.
Hepatoma Research (2025)
Open Access
Antiproliferative Activity and Apoptotic Mechanisms of β-Sitosterol and Its Derivatives as Anti-Breast Cancer Agents: In Silico and In Vitro
Mutakin Mutakin, Lauren Pangestu, Nafisa Nurfatia Hidayat, et al.
Journal of Experimental Pharmacology (2025) Vol. Volume 17, pp. 107-121
Open Access
The role of VEGF in Cancer angiogenesis and tumorigenesis: Insights for anti-VEGF therapy
Zhifeng Shi, Mengmeng Kuai, Baohua Li, et al.
Cytokine (2025) Vol. 189, pp. 156908-156908
Closed Access
Exosomal miR-125b Exerts Anti-Metastatic Properties and Predicts Early Metastasis of Hepatocellular Carcinoma
Hye-Seon Kim, Jin Seoub Kim, Na Ri Park, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 29
Extracellular vesicles in hepatology: Physiological role, involvement in pathogenesis, and therapeutic opportunities
Maria Azparren‐Angulo, Félix Royo, Esperanza González, et al.
Pharmacology & Therapeutics (2020) Vol. 218, pp. 107683-107683
Open Access | Times Cited: 29
Fighting Carcinogenesis with Plant Metabolites by Weakening Proliferative Signaling and Disabling Replicative Immortality Networks of Rapidly Dividing and Invading Cancerous Cells
Sally A. El‐Zahaby, Atif Khurshid Wani, Nahid Akhtar, et al.
Current Drug Delivery (2022) Vol. 20, Iss. 4, pp. 371-386
Closed Access | Times Cited: 18
Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma
Dongdong Xue, Jingzhao Han, Ze Liang, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 99-112
Open Access | Times Cited: 18
Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
Man Yao, Shufang Liang, Binbin Cheng
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Role of miRNA in pathogenesis, diagnosis, and prognosis in hepatocellular carcinoma
Yi Lv, Xiujuan Sun
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 9
New Insights into the Role of miR-29a in Hepatocellular Carcinoma: Implications in Mechanisms and Theragnostics
Ya‐Ling Yang, Yen‐Hsiang Chang, Chia‐Jung Li, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 219-219
Open Access | Times Cited: 21
Exosomal microRNA-25 released from cancer cells targets SIK1 to promote hepatocellular carcinoma tumorigenesis
Xiaoyu Fu, Yujing Tang, Wanfeng Wu, et al.
Digestive and Liver Disease (2021) Vol. 54, Iss. 7, pp. 954-963
Closed Access | Times Cited: 19
Exosomes and Extracellular Vesicles in Myeloid Neoplasia: The Multiple and Complex Roles Played by These “Magic Bullets”
Simona Bernardi, Mirko Farina
Biology (2021) Vol. 10, Iss. 2, pp. 105-105
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top